Absence or reduction of FHIT expression in most clear cell renal carcinomas

Cancer Research

Volumn 58, Issue 14, 1998, Pages 2946-2951

  Hadaczek, Piotr ^a   Siprashvili, Zurab ^b   Markiewski, Maciej ^a   Domagala, Wenancjusz ^a   Druck, Teresa ^b   McCue, Peter A ^c   Pekarsky, Yuri ^b   Ohta, Masataka ^b,d   Huebner, Kay ^b   Lubinski, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME FRAGILE SITE; CHROMOSOME TRANSLOCATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0032527899     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Zbar, B., Brauch, H., Talmage, C, and Linehan, M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.), 327: 721-724, 1987.
2. Ogawa, O., Kakehi, Y., Ogawa, K., Koshiba, M., Sugiyama, T., and Yoshida, O. Allelic loss at chromosome 3p characterizes clear cell type phenotype of renal cell carcinoma. Cancer Res., 51: 949-953, 1991.
3. Yamakawa, K., Monta, R., Takahashi, E., Hori, T., Ishikawa, J., and Nakamura, Y. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res., 51: 4707-4711, 1991.
4. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Paslier, D. L., Chumakov, I., Cohen, D., Chinault, C., Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
5. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F-M., Lubensky, I., Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
6. Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., Buys, C. H. C. M., and Maher, E. R. Somatic mutations of the Von Hippel Lindau disease tumour suppressor gene in nonfamilial clear cell renal carcinoma. Hum. Mol. Genet., 3: 2169-2173, 1994.
7. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I., and Yao, M. Frequent somatic mutations and loss of heterozygosity of the Von Hippel Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res., 54: 2852-2855, 1994.
8. Lubinski, J., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., McCue, P., Druck, T., and Huebner, K. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res., 54: 3710-3713, 1994.
9. Druck, T., Kastury, K., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., Ohta, M., LaForgia, S., Lasota, J., McCue, P., Lubinski, J., and Huebner, K. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res., 55: 5348-5353, 1995.
10. Hadaczek, P., Podolski, J., Toloczko, A., Kurzawski, G., Sikorski, A., Rabbitts, P., Huebner, K., and Lubinski, J. Accumulation of losses at 3p common deletion sites is characteristic of clear cell renal cell carcinoma. Virchows Arch., 429: 37-42, 1996.
11. Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. J., Tsai, S., Jacobs, S. C., and Brown, R. S. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med., 301: 592-595, 1979.
12. Li, F. P., Decker, H-J. H., Zbar, B., Stanton, V. P., Kovacs, G., Seizinger, B. R., Aburatani, H., Sandberg, A. A., Berg, S., Hosoe, S., and Brown, R. S. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Ann. Int. Med., 118: 106-111, 1993.
13. Wilhelm, M., Bugert, P., Kenck, C., Staehler, G., and Kovacs, G. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res., 55: 5383-5385, 1995.
14. van den Berg, A., Dijkhuizen, T., Draaijers, T. G., Hulsbeek, M. M. F., Maher, E. R., van den Berg, E., Storkel, S., and Buys, C. H. C. M. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development. Genes Chromosomes Cancer, 19: 228-232, 1997.
15. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t{3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
16. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., DeGregorio, L., Pastorino, V., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
17. Michael, D., Beer, D. G., Wilke, C. W., Miller, D. E., and Glover, T. W. Oncogene, 15: 1553-1559, 1997.
18. Druck, T., Hadaczek, P., Fu, T-B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
19. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA, 94: 14584-14589, 1997.
20. van den Berg, A., Draaijers, T. G., Kok, K., Timmer, T., Van der Veen, A. Y., Veldhuis, P. M. J. F., de Leij, L., Gerhartz, C. D., Naylor, S. L., Smith, D. I., and Buys, C. H. C. M. Normal FHIT transcripts in renal cell cancer-and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosomes Cancer, 19: 220-227, 1997.
21. van den Berg, A., Hulsbeek, M. M. F., de Jong, D., Kok, K., Veldhuis, P. M. J. F., Roche, V. J., and Buys, C. H. C. M. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes Cancer, 15: 64-72, 1996.
22. Bugert, P., Wilhelm, M., and Kovacs, G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer, 20: 9-15, 1997.
23. Shridhar, V., Wang, L., Rosati, R., Paradee, W., Shridhar, R., Mullins, C., Sakr, W., Grignon, D., Miller, O. J., Sun, Q. C., Petros, J., and Smith, D. I. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene, 14: 1269-1277, 1997.
24. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
25. Fuhrman, S., Lasky, L., and Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol., 6: 655-663, 1982.
26. Robson, C. J., Churchill, B. M., and Anderson, W. The results of radical nephrectomy for renal cell carcinomas. J. Urol., 101: 297-301, 1969.
27. Fromowitz, F. B., and Bard, R. H. Clinical implications of pathologic subtypes in renal cell carcinoma. Semin. Urol., 8: 31-50, 1990.
28. Wang, J., Darling, J., Zhang, J-S., Qian, C-P., Hartmann, L., Conover, C., Jenkins, R., and Smith, D. I. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact. Oncogene 16: 635-642, 1998.
29. Xiao, G-H., Jin, F., Klein-Szanto, A. J. P., Goodrow, T. L., Linehan, M. W., and Yeung, R. S. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers. Am. J. Pathol., 151: 1541-1547, 1997.
30. Greenspan, D. L., Connolly, D. C., Wu, R., Lei, R. Y., Vogelstein, J. T. C., Kim, Y-T., Mok, J. E., Munoz, N., Bosch, X., Shah, K., and Cho, K. R. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res., 57: 4692-4698, 1997.
31. Sozzi, G., Tornielli, S., Tagliabue, E., Sard, L., Pezzella, F., Pastorino, U., Minoletti, F., Pilotti, S., Ratcliffe, C., Veronese, M. L., Goldstraw, P., Huebner, K., Croce, C. M., and Pierotti, M. A. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res., 57: 5207-5212, 1997.